The move targets a high-value niche in the European bioeconomy, offering a scalable model for sustainable Amazonian exports.

The Colombian government has formally submitted a technical and scientific dossier to the European Union seeking authorization to market cacay flour as a “Novel Food.” This regulatory category governs the entry of non-traditional food products into the European market.

The submission is the first of its kind for an Amazonian product from Colombia. It follows a 2024 initiative involving the Ministry of Commerce, Industry, and Tourism and the [suspicious link removed]. The process was supported by the Sustainable Forest Territories (Territorios Forestales Sostenibles or TEFOS 3) project, a program funded by the British Embassy and the German Cooperation GIZ.

Diana Marcela Morales Rojas, the Minister of Commerce, Industry, and Tourism, stated that the application positions cacay as a strategic component of the national portfolio of high-value natural ingredients. The technical dossier was structured according to the guidelines of the European Food Safety Authority (EFSA). To meet these standards, Colombia provided evidence of safe historical consumption for at least 25 years, alongside data on nutritional profiles, safety, traceability, and sustainable production processes.

The administrative validation phase is expected to take one month, followed by a technical and scientific evaluation by EFSA that may last up to nine months. Six Colombian companies participated in the drafting of the expediente, providing technical data and validating industrial processes to demonstrate the feasibility of large-scale production under international standards.

“This step positions the cacay as a strategic ingredient within the Colombian portfolio of high-value-added natural products.” — Diana Marcela Morales Rojas, Minister of Commerce, Industry, and Tourism.

The cacay nut, native to the Amazon and Orinoquia regions, produces a seed containing up to 60% oil rich in omega-6 and omega-9. The flour, a byproduct of the oil extraction process, contains approximately 40% protein and high fiber content. Beyond its nutritional applications, the crop is integrated into agroforestry systems aimed at restoring degraded lands and promoting biodiversity.

Currently, the cacay value chain involves more than 500 peasant and indigenous families. If approved, the flour would join Colombia’s non-traditional export basket to Europe, reinforcing a bioeconomy model based on fair trade and the sustainable use of biodiversity.

Colombian President Gustavo Petro is continuing to make changes to Colombia’s health system through administrative measures, after two attempts to pass a legislative reform were rejected by Congress.

The latest decision is Decree 0182 of 2026, which centralizes the provision of health services in approximately 45% of the country under the administration of Nueva EPS, a mixed public-private company currently under government intervention. As part of the measure, the insurer would receive 2,84 million reassigned members.

According to the government, the decree seeks to modify the flow of resources within the system so that funds would be paid from the government directly to healthcare providers, such as hospitals and clinics. This change would limit the traditional role of the Entidades Prestadoras de Salud (EPS), the system’s intermediaries, whose reduction has been one of the Petro administration’s key policy goals.

President Petro has publicly defended this approach. In a message posted on the social media platform X, he said that EPS entities “devour 70 trillion pesos annually and demonstrably benefit the wealth of their owners.” The president has also blamed these institutions for the crisis affecting the health sector over the past decade, arguing that during that time “the theft of health resources multiplied, and 117 EPS were liquidated to avoid paying their debts.”

The decree has sparked debate in the media. Some reports, including those published by the outlet Infobae after reviewing the official document, described the measure as a “mass transfer of patients and territorial reorganization of the health system.” However, the Ministry of Health rejected that interpretation and clarified that the measure “does not involve an arbitrary transfer of users, but rather a technical step aimed at correcting structural failures in the insurance model”.

In a statement, the ministry explained that “when an EPS lacks operational or financial capacity in a given territory, the state is authorized to adopt temporary mechanisms to ensure healthcare access for users.” The ministry also stated that the goal of the decree is to guarantee effective, fair, dignified and continuous access to healthcare services across the country, particularly in regions where geographic dispersion and low population density have historically complicated service delivery.

Political and administrative context

The debate comes amid a broader process of administrative interventions within the system. According to reports cited by the newspaper El Colombiano, “over the past three years the government, through the Superintendencia Nacional de Salud, has intervened in seven EPS,” removing their management from private owners and placing them under state-appointed administrators.

The government has used this context to justify administrative measures such as those included in the decree, arguing that several insurers have demonstrated structural operational weaknesses. At the same time, the legislative debate over a comprehensive health reform has not been completely closed. According to the same outlet, the government is still exploring the possibility of reviving the reform bill through an appeal filed by Senator Fabián Díaz. In the meantime, the administration has moved forward with changes through decrees, regulatory resolutions and decisions by the health regulator.

Despite the publication of the decree, its implementation still requires additional administrative steps. According to analysis cited by Infobae, “the transfer of members will not occur automatically, as it depends on the Superintendencia Nacional de Salud issuing administrative acts that update the territorial scope of the EPS”. This means the reorganization of the system could unfold gradually once the required regulatory procedures are completed.

The US Animal and Plant Health Inspection Service (APHIS) has authorized the entry of Colombian shell eggs destined for industrial processing, according to an announcement made by Diana Marcela Morales Rojas, Minister of Commerce, Industry and Tourism (MinCIT). This decision expands the export capacity for Colombia’s poultry sector by allowing the product to enter the US market without requiring additional import permits or sanitary certificates from the Colombian Government.

The authorization by APHIS follows technical and commercial discussions between US and Colombian regulatory bodies. Minister Morales Rojas stated that the outcome enables the poultry industry to expand its presence in international markets and integrate into higher-standard value chains.

The regulatory modification is the result of collaboration between the Government of Colombia, the Instituto Colombiano Agropecuario (ICA), the Ministry of Commerce, Industry and Tourism, the Embassy of Colombia in the United States, and the Federación Nacional de Avicultores (Fenavi), the trade association representing the poultry sector.

Six US facilities have been designated to receive the Colombian shell eggs for processing. These plants are situated in the states of New York, Pennsylvania, New Jersey, Arkansas, and Georgia. The direct entry authorization for industrial use simplifies the logistics and required sanitary compliance for the export of the product.

Above photo: Colombia’s Minister of Commerce, Industry and Trade, Diana Marcela Morales (courtesy MinCIT)